[HTML][HTML] Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

CH Tai, NC Lee, YH Chien, BJ Byrne, SI Muramatsu…�- Molecular Therapy, 2022 - cell.com
Aromatic L-amino acid decarboxylase deficiency results in decreased neurotransmitter
levels and severe motor dysfunction. Twenty-six patients without head control received�…

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

CH Tai, NC Lee, YH Chien, BJ Byrne…�- …�therapy: the journal�…, 2022 - pubmed.ncbi.nlm.nih.gov
Aromatic L-amino acid decarboxylase deficiency results in decreased neurotransmitter
levels and severe motor dysfunction. Twenty-six patients without head control received�…

[HTML][HTML] Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

CH Tai, NC Lee, YH Chien, BJ Byrne, SI Muramatsu…�- Molecular Therapy, 2022 - Elsevier
Aromatic L-amino acid decarboxylase deficiency results in decreased neurotransmitter
levels and severe motor dysfunction. Twenty-six patients without head control received�…

[CITATION][C] Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

CH Tai, NC Lee, YH Chien, BJ Byrne, SI Muramatsu…�- Molecular�…, 2022 - cir.nii.ac.jp
Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ�…

[HTML][HTML] Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency

CH Tai, NC Lee, YH Chien, BJ Byrne…�- Molecular�…, 2022 - ncbi.nlm.nih.gov
Aromatic L-amino acid decarboxylase deficiency results in decreased neurotransmitter
levels and severe motor dysfunction. Twenty-six patients without head control received�…

Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency.

CH Tai, NC Lee, YH Chien, BJ Byrne…�- …�Therapy: the Journal�…, 2021 - europepmc.org
Aromatic L-amino acid decarboxylase deficiency results in decreased neurotransmitter
levels and severe motor dysfunction. Twenty-six patients without head control received�…